Clinical and radiological features related to the growth potential of meningioma

Neurosurgical Review

Volumn 29, Issue 4, 2006, Pages 293-297

  Kasuya, Hidetoshi ^a   Kubo, Osami ^a   Tanaka, Masahiko ^a   Amano, Kosaku ^a   Kato, Koichi ^a   Hori, Tomokatsu ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Growth; Meningioma; MIB 1

Indexed keywords

KI 67 ANTIGEN;

ADULT; AGE; ARTICLE; BRAIN RADIOGRAPHY; CALCIFICATION; CLINICAL FEATURE; EDEMA; FEMALE; HUMAN; HUMAN TISSUE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; PRIORITY JOURNAL; RISK FACTOR; SKULL BASE; STAINING; SYMPTOMATOLOGY; TUMOR GROWTH; TUMOR RECURRENCE; TUMOR VOLUME; WORLD HEALTH ORGANIZATION;

EID: 33748606633     PISSN: 03445607     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10143-006-0039-3     Document Type: Article

References (21)

1. Aguiar PH, Tsanaclis AM, Tella OI, Plese JP (2003) Proliferation rate of intracranial meningiomas as defined by the monoclonal antibody MIB-1. Neurosurg Rev 26:221-228
2. Cattoretti G, Becker MHG, Key G, Duchrow M, Schluter C, Galle J, Gerdes J (1992) Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 168:357-363
3. Ho DMT, Hsu CY, Ting LT, Chiang H (2002) Histopathology and MIB-1 labeling index predicted recurrence of meningiomas. Cancer 94:1538-1547
4. Ide M, Jimbo M, Yamamoto M, Umebara Y, Hagiwara S, Kubo O (1996) MIB-1 staining index and peritumoral brain edema of meningiomas. Cancer 78:133-143
5. Jaaskelainen J, Haltia M, Laasonen E, Wahlstrom T, Valtonen S (1985) The growth rate of intracranial meningiomas and its relation to histology. Surg Neurol 24:165-172
6. Kakinuma K, Tanaka R, Onda K, Takahashi H (1998) Proliferative potential of recurrent intracranial meningiomas as evaluated by labelling indices of BUdR and Ki-67, and tumour doubling time. Acta Neurochir 140:26-32
7. Kalala JP, Caemaert J, de Ridder L (2004) Primary resected meningiomas: relapses and proliferation markers. In vivo 18:411-416
8. Kayaselcuk F, Zorludemir S, Bal N, Erdogan B, Erman T (2004) The expression of surviving and Ki-67 in meningiomas: correlation with grade and clinical outcome. J Neuro-Oncol 67:209-214
9. Kuratsu J, Kochi M, Ushio Y (2000) Incidence and clinical features of asymptomatic meningiomas. J Neurosurg 92:766-770
10. Louis DN, Scheithauer BW, Budka H, von Deimling A, Kepes JJ (2000) Meningiomas. In: Kleihues P, Cavenee WK (eds) World Health Organization classification of tumours. Pathology and genetics of tumours of the nervous system. IARCPress, Lyon, France pp176-184
11. Matsuno A, Fujimaki T, Sasaki T, Nagashima T, Ide T, Asai A, Matsuura R, Utsunomiya H, Kirino T (1996) Clinical and histopathological analysis of proliferative potentials of recurrent and non-recurrent meningiomas. Acta Neuropathol 91:504-510
12. Nakaguchi H, Fujimaki T, Matsuno A, Matsuura R, Asai A, Suzuki I, Sasaki T, Kirino T (1999) Postoperative residual tumor growth of meningioma can be predicted by MIB-1 immunohistochemistry. Cancer 85:2249-2254
13. Nakamura M, Roser F, Michel J, Jacobs C, Samii M (2003) The natural history of incidental meningiomas. Neurosurgry 53:62-71
14. Nakasu S, Hirano A, Shimura T, Llena JF (1987) Incidental meningiomas at autopsy study. Surg Neurol 27:319-322
15. Nakasu S, Nakajima M, Matsumura K, Nakasu Y, Handa J (1995) Meningioma: proliferating potential and clinicoradioloical features. Neurosurgery 37:1049-1055
16. Niiro M, Yatsushiro K, Nakamura K, Kawahara Y, Kuratsu J (2000) Natural history of elderly patients with asymptomatic meningiomas. J Neurol Neurosurg Psychiatry 68:25-28
17. Olivero WC, Lister JR, Elwood PW (1995) The natural history and growth rate of asymptomatic meningiomas: a review of 60 patients. J Neurosurg 83:222-224
18. Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM (1998) The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas. Cancer 82:2262-2269
19. Roser F, Samii M, Ostertag H, Bellinzona M (2004) Clinicopathological study. The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases. Acta Neurochir 146:37-44
20. Whittle IR, Smith C, Navoo P, Collie D (2004) Meningiomas. Lancet 363:1535-43
21. Yoneoka Y, Fujii Y, Tanaka R (2000) Growth of incidental meningiomas. Acta Neurochir 142:507-511